Related references
Note: Only part of the references are listed.Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools
Lorenzo Gerratana et al.
EUROPEAN JOURNAL OF CANCER (2021)
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
M. J. M. Magbanua et al.
ANNALS OF ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
Olga Martinez-Saez et al.
NPJ BREAST CANCER (2021)
Serial circulating tumor DNA identification associated with the efficacy and prognosis of neoadjuvant chemotherapy in breast cancer
Yidong Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
Po-Han Lin et al.
FRONTIERS IN ONCOLOGY (2021)
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial
Jose Manuel Perez-Garcia et al.
LANCET ONCOLOGY (2021)
Genomic profile of advanced breast cancer in circulating tumour DNA
Belinda Kingston et al.
NATURE COMMUNICATIONS (2021)
SWnet: a deep learning model for drug response prediction from cancer genomic signatures and compound chemical structures
Zhaorui Zuo et al.
BMC BIOINFORMATICS (2021)
Association of 17q22 Amplicon Via Cell-Free DNA With Platinum Chemotherapy Response in Metastatic Triple-Negative Breast Cancer
Katharine A. Collier et al.
JCO PRECISION ONCOLOGY (2021)
Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer
Xiuwen Guan et al.
BREAST (2020)
A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer
Susana Torres et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2020)
Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options
Giulia Grizzi et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Prognostic impact of ESR1 mutations in ER+ HER2- MBC patients prior treated with first line AI and palbociclib: An exploratory analysis of the PADA-1 trial.
Francois Clement Bidard et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial
Milan Radovich et al.
JAMA ONCOLOGY (2020)
Machine learning approaches to drug response prediction: challenges and recent progress
George Adam et al.
NPJ PRECISION ONCOLOGY (2020)
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial
Nicholas C Turner et al.
LANCET ONCOLOGY (2020)
Inherited causes of clonal haematopoiesis in 97,691 whole genomes
Alexander G. Bick et al.
NATURE (2020)
Clonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications
Hiu Ting Chan et al.
CANCERS (2020)
Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative review
Oraianthi Fiste et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Circulating Tumor DNA and Biomarker Analyses From the LOTUS Randomized Trial of First-Line Ipatasertib and Paclitaxel for Metastatic Triple-Negative Breast Cancer
Matthew J. Wongchenko et al.
JCO PRECISION ONCOLOGY (2020)
Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors
Pedram Razavi et al.
NATURE CANCER (2020)
Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial
Francoise Rothe et al.
CLINICAL CANCER RESEARCH (2019)
Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer
Yidong Zhou et al.
MOLECULAR ONCOLOGY (2019)
Liquid biopsy and minimal residual disease - latest advances and implications for cure
Klaus Pantel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
Raoul Charles Coombes et al.
CLINICAL CANCER RESEARCH (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
Isaac Garcia-Murillas et al.
JAMA ONCOLOGY (2019)
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
Bradon R. McDonald et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer et al.
NATURE REVIEWS GENETICS (2019)
ESR1 mutations in metastatic lobular breast cancer patients
Christine Desmedt et al.
NPJ BREAST CANCER (2019)
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle (vol 25, pg 1729, 2014)
L. De Mattos-Arruda et al.
ANNALS OF ONCOLOGY (2018)
Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer
N. Guibert et al.
ANNALS OF ONCOLOGY (2018)
The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature
Janine Aucamp et al.
BIOLOGICAL REVIEWS (2018)
The emerging clinical relevance of genomics in cancer medicine
Michael F. Berger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients
Bente Risberg et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial
Ben O'Leary et al.
CANCER DISCOVERY (2018)
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
N. C. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
Giovanna Rossi et al.
CLINICAL CANCER RESEARCH (2018)
Intrinsic HER2 V777L mutation mediates resistance to trastuzumab in a breast cancer patient
Yosuke Hirotsu et al.
MEDICAL ONCOLOGY (2017)
Lesion-Directed Therapies and Monitoring Tumor Evolution Using Liquid Biopsies
Mariangela Russo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?
Arkadius Polasik et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer case
Valentina Appierto et al.
SEMINARS IN CANCER BIOLOGY (2017)
Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker
Ru Wang et al.
ONCOTARGET (2017)
Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis
Ziqiang Lin et al.
ONCOTARGET (2017)
A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications
Ashraful Haque et al.
GENOME MEDICINE (2017)
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer
Cynthia X. Ma et al.
CLINICAL CANCER RESEARCH (2017)
Emerging concepts in liquid biopsies
Samantha Perakis et al.
BMC MEDICINE (2017)
Patient -Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple -Negative Breast Cancer
Francesca Riva et al.
CLINICAL CHEMISTRY (2017)
Correlation of Methylated Circulating Tumor DNA With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
Hiroyo Takahashi et al.
CLINICAL BREAST CANCER (2017)
Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer
Kokoro Kobayashi et al.
SURGERY TODAY (2016)
Origins, structures, and functions of circulating DNA in oncology
A. R. Thierry et al.
CANCER AND METASTASIS REVIEWS (2016)
Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer
Wen-Jia Zuo et al.
CLINICAL CANCER RESEARCH (2016)
Liquid Biopsy in Metastasized Breast Cancer as Basis for Treatment Decisions
Natalia Krawczyk et al.
ONCOLOGY RESEARCH AND TREATMENT (2016)
Current practices and guidelines for clinical next-generation sequencing oncology testing
Samuel P. Strom et al.
Cancer Biology & Medicine (2016)
Measurement of Circulating Cell-Free DNA Levels by a Simple Fluorescent Test in Patients With Breast Cancer
Ravit Agassi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
Eleonor Olsson et al.
EMBO MOLECULAR MEDICINE (2015)
Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology
Eser Kirkizlar et al.
TRANSLATIONAL ONCOLOGY (2015)
The Plasma DNA Concentration as a Potential Breast Cancer Screening Marker
Orathai Tangvarasittichai et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2015)
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Julia A. Beaver et al.
CLINICAL CANCER RESEARCH (2014)
DNA Methylation and miRNAs Regulation in Hereditary Breast Cancer: Epigenetic Changes, Players in Transcriptional and Post-Transcriptional Regulation in Hereditary Breast Cancer
R. Pinto et al.
CURRENT MOLECULAR MEDICINE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial
Anthony B. Miller et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
The dynamic range of circulating tumor DNA in metastatic breast cancer
Maryam Heidary et al.
BREAST CANCER RESEARCH (2014)
Circulating cell free DNA: Preanalytical considerations
Safia El Messaoudi et al.
CLINICA CHIMICA ACTA (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer
A. Prat et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients
Gayatri Sharma et al.
TUMOR BIOLOGY (2012)
Long-term toxic effects of adjuvant chemotherapy in breast cancer
H. A. Azim et al.
ANNALS OF ONCOLOGY (2011)
Deconstructing the molecular portraits of breast cancer
Aleix Prat et al.
MOLECULAR ONCOLOGY (2011)
Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975
C. La Vecchia et al.
ANNALS OF ONCOLOGY (2010)
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients
Gayatri Sharma et al.
LIFE SCIENCES (2010)
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
Fiona M. Blows et al.
PLOS MEDICINE (2010)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients
Zhao Hui Huang et al.
CANCER LETTERS (2006)
Circulating tumor-specific DNA: A marker for monitoring efficacy of adjuvant therapy in cancer patients
H Fiegl et al.
CANCER RESEARCH (2005)
Changes in concentration of DNA in serum and plasma during storage of blood samples
M Jung et al.
CLINICAL CHEMISTRY (2003)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
